Irrespective of the underlying pathogenesis, a broad spectrum of gastrointestinal (GI) diseases result in disruption of the protective mucosal barrier. This breech of mucosal integrity results in further injury to underlying submucosal structures. There is a clear requirement for rapid healing of the GI wall to maximize preservation of normal structure and function. Necrotizing enterocolitis (NEC) is a disease of premature infants that is characterized pathologically by varying degrees of bowel wall inflammation and necrosis and intraluminal bacterial overgrowth (1) . The incidence and case-fatality rates for infants with NEC increase with decreasing gestational age and birth weight (2) . In very low birth weight infants (Ͻ1500 g), the incidence of NEC is 5-15% in most neonatal intensive care units, with a mortality of 10 -44% (2, 3) . There is also significant morbidity associated with NEC, including sepsis, bowel perforation, intestinal strictures, short bowel syndrome, and complications of long-term total parenteral nutrition that lead to prolonged hospitalization. Although multiple factors have been postulated to play a role in the development of the disease, the exact cause remains unclear (4) . As such, preventive strategies based on our current understanding of NEC have not significantly decreased the incidence, mortality, or morbidity in premature infants who develop NEC.
In current clinical practice, the principal treatment is conservative medical management, which involves withholding enteral feeds, total parenteral nutrition, i.v. antibiotics, correction of fluid and electrolyte abnormalities, treatment of coagulopathy, and close observation for evidence of bowel perforation. Surgical intervention for intractable cases of NEC with or without evidence of bowel perforation usually involves significant bowel resection. Thus, surgery is avoided unless absolutely necessary. Even in infants who have NEC and are treated successfully with a conservative regimen, a significant number (6 -33%) result in obstructive intestinal strictures (5), requiring resection and/or percutaneous bypass. The present manage-ment is not designed to modify the rate and quality of healing in the diseased parts of the bowel. If intestinal wound healing could be modulated to enhance the replacement of injured tissue with functional intestinal tissue, then it would be possible to significantly decrease the amount of bowel that is ultimately damaged.
It has been established that a substantial number of peptide growth factors play specific roles in wound healing (6) . Although the role of specific growth factors has not been as clearly delineated for GI wound healing, it seems that transforming growth factor-␤ 1 (TGF-␤ 1 ) plays a central role. Active TGF-␤ 1 , a 25-kD dimeric peptide (7), has been shown to modulate chemotaxis of monocytes, macrophages, and epithelial cells (6) ; epithelial restitution (8) ; deposition of extracellular matrix (ECM) proteins (9); and neovascularization (10) during wound healing. The application of TGF-␤ 1 to GI incisional wounds has been shown to increase wound strength (11) .
Large reservoirs of latent TGF-␤ 1 and its receptors are present in human tissues and are ubiquitous in distribution (12) . The activation of latent TGF-␤ 1 requires its binding to IGF-II/mannose-6-phosphate cell surface receptors (13) followed by proteolytic cleavage of the latency associated protein and latent TGF-␤ binding protein by cell surface proteases (14) . Agents that modulate TGF-␤ 1 activation include vitamin A, which facilitates receptor binding of latent TGF-␤ 1 and increases plasmin levels (15) .
Treatment of skin wounds with vitamin A results in accelerated wound healing and increased wound strength (16) . Only a few studies have evaluated the effect of vitamin A on GI wound healing (17) (18) (19) . The beneficial effect of vitamin A treatment on wound healing may, in part, be the result of augmented activation of tissue stores of latent TGF-␤ 1 . The aims of this study were to determine whether vitamin A treatment is effective for 1) enhancing intestinal wound healing in vitro and 2) increasing activation of TGF-␤ 1 during wound healing.
METHODS
All animal studies were performed at the University of Ottawa Animal Care Facilities (Ottawa, Ontario, Canada). All animal handling and procedures were reviewed and approved by the University of Ottawa Animal Care Committee to conform to the Canadian Council on Animal Care's Guide to the Care and Use of Experimental Animals and with the Animals for Research Act.
NEC animal model. A modification of the model of NEC originally described by Clark and Miller (20) was adapted to the newborn piglet (21) . This model utilizes an intraluminal chemical induction of NEC. One-week-old Yorkshire piglets (Agriculture Canada) of normal birth weight were used for these studies. Full-thickness distal ileal tissue was harvested for tissue culture from six piglets. Each animal was its own control. Acidified casein was injected into the NEC intestinal segments. Normal saline was injected into the adjacent control intestinal segments.
The animals remained sedated and intubated during the surgical procedures. Laparotomy was performed via a midline incision. Without causing ischemia, a ligature was placed at the proximal ileum and flushed distally with warm sterile saline using a transmural 26-gauge needle. Placing ligatures created two intestinal loops at 10-cm intervals proximal and distal to the ileocecal valve. Sterile 0.9% saline or test solution consisting of bovine casein (10 mg/mL) and calcium gluconate (50 mg/mL; Sigma Chemical Co.-Aldrich, St. Louis, MO, U.S.A.) acidified to pH 4.0 with propionic acid was injected into these distal ileum and proximal colon loops (control). A 26-gauge needle was used to inject these solutions into the lumen of the ligated bowel loops at a volume of 1 mL/2 cm length of intestine. The control loop was separated from the treated loop by an untreated "interloop" to avoid extension of the inflammatory process from the treated to the control loop. The abdominal cavity was closed, and the animals were allowed to recover. The piglets were kept nil by mouth and maintained on continuous i.v. dextrose in water (10%) and electrolyte solutions (75 mmol/L sodium chloride, 20 mmol/L potassium chloride, 22.4 mmol calcium/L calcium gluconate) at a rate of 200 mL · kg Ϫ1 · 24 h Ϫ1 ·. Demerol (1 mg/kg i.m.) was administered as needed for analgesia. The piglets were reanesthetized after 3 h, and the abdominal cavity was entered and the ligated intestinal loops were excised and inspected macroscopically for lesions. The excised ileal tissue to be used for culture was placed in ice-cold Hanks solution (GIBCO BRL, Grand Island, NY, U.S.A.) for transport. The tissue was placed in cold (4°C) 0.9% sodium hypochlorite/PBS for 30 min to decrease microorganism contamination. Additional tissue was frozen immediately in liquid nitrogen and stored at Ϫ100°C for further analyses. The animals were killed with intracardiac sodium pentobarbital (65 mg/mL).
Explant culture. Ileal tissue was cut into 25-mm 2 sections and placed villus side up on a Gelfoam platform (Pharmacia & Upjohn, Peapack, NJ, U.S.A.) in 4-mL Falcon culture plates. Four ileal sections were cultured from each of the NEC and control ileal segments for each piglet. Serum-free Dulbecco's modified Eagle's medium/F-12 culture medium (GIBCO BRL) was added to allow the explants to sit at the air-liquid interface. The culture medium was supplemented with 100 U/mL penicillin, 100 pg/mL streptomycin, 0.1 pg/mL amphotericin B, 5.0 pg/mL gentamicin, and 0.3 mg/mL ascorbic acid. Medium was changed every 24 h. The culture plates were placed on a rocker platform at six cycles per minute and incubated at 37°C with a 95% O 2 and 5% CO 2 gas mixture. These conditions were found to optimize preservation of normal gut wall morphology in porcine intestinal explants over a 48-h culture period (22) . All-trans retinol (ATR; Sigma Chemical Co) was added to the culture medium to achieve 2, 5, and 10 M.
Histology. Tissue was fixed in 10% formaldehyde and embedded in polyester wax. Sections (5 m) were prepared by standard techniques and were stained with Carazzi's hematoxylin for microscopic evaluation. Two randomly selected sections for each ileal explant were assessed for the degree of bowel wall injury, percentage of intact mucosal epithelium, and villus height. A standardized histologic scoring system (Table 1 ) was used to evaluate the degree of bowel wall injury (20) . Under ϫ5 magni-936 YUEN AND STRATFORD fication, measurements of the mucosal surface were made with the aid of the micron grid. The percentage of the mucosal surface covered with intact epithelium was calculated [length of mucosal surface lined with intact epithelium ()/total length of mucosal surface () ϫ 100]. The villus height reported for each ileal explant represents the average villus height (all villi visualized in the field of ϫ10 magnification were measured from villus tip to the junction of the lamina propria and muscularis mucosae). Two researchers who were blinded to the culture medium composition independently performed the histologic scoring and measurements.
Western blot. Tissue previously frozen at Ϫ100°C was homogenized in SDS-Stop. The protein content of the samples was measured with the Bio-Rad colorimetric method against a BSA (Bio-Rad Laboratories, Hercules, CA, U.S.A.) standard curve. Total protein was extracted from the tissue samples after paraffin fixation through SDS-PAGE. Samples of equal protein content (20 g) were loaded and run on a 10% (wt/vol) SDS polyacrylamide mini-gel under nonreducing conditions. A standard broad-range protein ladder (Bio-Rad Laboratories) was run simultaneously on the same gel. Proteins were transferred onto a nitrocellulose membrane at 80 mV in a Bio-Rad wet transfer apparatus for 1 h and blocked with a 2% milk solution. The membrane was incubated overnight at 4°C with mouse monoclonal anti-human TGF-␤ 1 antibody (Serotec, Raleigh, NC, U.S.A.) followed by incubation with fluoresceinconjugated anti-mouse antibody (Oncogene Science, Cambridge, MA, U.S.A.) for 1 h. Immunofluorescence was induced with ECL reagents (Amersham Scientific, Buckinghamshire, England), and the membrane was exposed on Kodak Hyperspeed film for 10 min. The latent TGF-␤ 1 band is found at 200 -230 kD, the propeptide at 50 kD, and active TGF-␤ 1 dimer at 20 -25 kD .
Statistical analyses. Histologic data were analyzed by ANOVA with posttest t test to evaluate for differences between groups. The level of significance was p Ͻ 0.05.
RESULTS
There was improved recovery of normal gut wall cytoarchitecture of full-thickness ileal NEC explants cultured for 24 and 48 h with all tested concentrations of ATR (Figs. 1-3) . After 24 h of culture, 2 M ATR resulted in the most significant improvement in healing compared with 5 and 10 M ATR (Fig. 1) . There was further healing noted at 48 h with 5 and 10 M ATR. However, the degree of healing remained less than that achieved with 2 M ATR at either time points. Improved recovery of gut wall cytoarchitecture was also noted at 48 h for the ileal explants cultured without added ATR but was significantly less than that observed for explants cultured with supplemental ATR (Fig. 1) .
Recovery of mucosal surface epithelium was significantly improved with 2 M ATR after 24 and 48 h compared with explants cultured without added ATR (Fig. 2) . After 48 h, there was decreased mucosal epithelial integrity of the explants Transmural necrosis Figure 1 . Effect of ATR on wound healing of injured full-thickness porcine ileum explants cultured up to 48 h. Histologic evaluation was performed on injured full-thickness porcine ileum explants cultured for 24 or 48 h in culture medium that was supplemented with or without ATR (2-10 M). Paraffinembedded, hematoxylin-and eosin-stained ileum sections were evaluated for the extent of ileal wall damage using a standardized scoring system (Table 1) . Histologic grades range from 0 (normal gut wall cytoarchitecture) to 4 (full-thickness gut wall necrosis). Values are expressed as mean Ϯ SD. Data sets with one common superscript are not significantly different (p Ն 0.05).
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VITAMIN A AND WOUND HEALING cultured without additional ATR, whereas explants cultured with any concentration of supplemental ATR maintained the degree of epithelial integrity achieved at 24 h of culture. There was no further improvement in recovery of mucosal epithelium at 48 h compared with 24 h in the ATR-supplemented explants. Recovery of villi height was observed for explants cultured with all concentrations of supplemental ATR and reached significance with 2 M ATR after 24 h and 2 and 5 M after 48 h (Fig. 3) . There was no further significant improvement in recovery of villi at 48 h compared with 24 h of culture with all concentrations of ATR except for 5 M.
The addition of ATR to the culture medium of noninjured control porcine ileal explants did not result in any histologic changes over a 48-h culture period compared with explants cultured without supplemental ATR (Table 2) . NEC explants cultured for 48 h without supplemental ATR or with the optimal dose of ATR (2 M) were used for Western blot identification of TGF-␤ 1 . Under nonreducing conditions, the active TGF-␤ 1 dimer was identified only from the explants cultured with supplemental ATR (Fig. 4) .
DISCUSSION
The results of this study demonstrate that vitamin A enhances wound healing of injured full-thickness porcine ileal explants in vitro without causing any observable adverse effects on normal ileal cytoarchitecture. The increased activation of tissue stores of TGF-␤ 1 with vitamin A may, in part, be responsible for the improved ileal wound healing. These findings suggest that vitamin A holds the potential as an effective adjuvant medical therapy for accelerating GI wound healing.
Over the 48-h study period, addition of vitamin A to the culture medium resulted in the accelerated recovery of the overlying mucosal epithelium and villus structures. Rapid recovery of an intact mucosal barrier after GI injury would provide greater protection of the underlying gut wall structures from damage, as a result of exposure to noxious intraluminal contents once the mucosal barrier is breached. As such, treatment with vitamin A after GI injury may decrease the extent of gut wall damage, which would have an impact on decreasing 938 the mortality rate and the risk of developing associated morbidities such as need for surgical bowel resection and development of intestinal strictures, short gut syndrome, and septicemia. The mechanism by which vitamin A accelerates intestinal epithelial restitution after mucosal injury is not known. The limited number of studies on the cellular and molecular mechanisms of GI wound healing have shown that intestinal mucosal healing occurs in two phases: 1) restitution, involving the migration of sheets of enterocytes across the mucosal defect, which starts within minutes from the time of injury, and 2) proliferation of mucosal epithelial cells, which starts in the order of hours from the time of injury (23, 24) . Growth factors that promote intestinal epithelial migration seem to achieve this effect through activation of TGF-␤ 1 , which may be the final common signal in this cytokine-mediated cascade (8) . As such, the increased activation of TGF-␤ 1 with vitamin A observed in our study may, in part, account for the improved recovery of mucosal epithelium after injury. Various ECM proteins of the basal lamina and epithelial cell integrin expression have been shown to influence epithelial cell migration and differentiation (25, 26) . Because vitamin A and TGF-␤ 1 modulate ECM protein synthesis and integrin expression (9, 27, 28) , this may be another mechanism by which these compounds modulate wound healing.
The addition of vitamin A to the culture medium of injured porcine ileal explants improved recovery of villi. However, these histologic observations do not provide information on the extent of recovery of the normal functional capacity of the villi. Growth factors, ECM proteins, and integrins, as discussed previously in relation to epithelial cell migration, have also been shown to play important roles during GI adaptation after injury (29, 30) .
Current management of NEC does not include specific therapies for enhancing GI wound healing. On the basis of our findings, vitamin A treatment of premature infants who develop NEC holds the potential of conferring the following benefits: 1) accelerate recovery of the intestinal mucosal epithelial barrier, 2) minimize the severity and extent of intestinal injury, and 3) enhance recovery of normal mucosal function. Follow-up studies will be conducted to test the in vivo efficacy of vitamin A treatment on enhancing GI wound healing in the newborn piglet model for NEC.
